Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of AuroLase(tm) Therapy in Patients With Refractory and/or Recurrent Tumors of the Head and Neck

NCT00848042 is registered in ClinicalTrials.gov with Nanospectra Biosciences, Inc. as lead sponsor.

NCT NCT00848042
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00848042 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of AuroLase(tm) Therapy in Patients With Refractory and/or Recurrent Tumors of the Head and Neck
Lead sponsor
Nanospectra Biosciences, Inc.
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2008
Completion date
August 31, 2014
Enrollment
11 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

head and neck cancer